As part of the White House's Cancer Moonshot Initiative, today, SHARE For Cures (www.SHAREForCures.org) launched a technology platform and study aimed to gather a better understanding of the real-world use of novel cancer immunotherapy drugs.
SHARE For Cures' new SHARE platform will easily and securely gather clinical, wellness, lifestyle, and patient-reported data about cancer immunotherapy use, side effects and benefits. Once gathered, the data will enable researchers to better understand how these new therapies are being used outside of clinical trials, as well as the health impact of specific drugs on real-world patients.
The Johns Hopkins University earned $58 million in licensing revenue in its 2016 fiscal year, three times more than in the prior year.
Johns Hopkins Technology Ventures, the university's commercialization office, attributed the spike in part to a major sublicensing deal between one of its portfolio companies, Immunomic Therapeutics, and Japanese pharmaceutical company Astellas Pharma.
NATURE OF WORK
The Senior Grants and Contracts Manager will be tasked with the preparation, drafting, review and negotiation of contractual agreements with a special emphasis on agreements that support biomedical research initiatives and partnerships. S/he should have a strong customer service orientation and be able to identify process improvements so that transactions are completed with the right balance of efficiency and risk mitigation. S/he will report to the Director of Operations but will serve the contracting needs of colleagues across the Foundation. Strong writing, analytical and organizational skills must be matched with a sense of flexibility, entrepreneurial spirit and good cheer.
October 27, 2016 - Arnold & Porter LLP, 601 Massachusetts Avenue, NW Washington, DC, 20001
The Washington DC/Baltimore Chapter of Women In Bio is presenting a program to learn about board service in the public and private sectors. If you are a budding entrepreneur looking to develop a board, this is the event for you. If you were recently named to a board and want to know more about your responsibilities, this is the event for you. If you want to start a business/nonprofit and need to know how to set up a board, this is the event for you.
Moderated by Mr. Yusuf Azuzullah, Chairman Board of Directors, Global Board Advisors Corp (GBAC), panelists include:
- Ms. Rachel King, CEO and President of GlycoMimetics, Inc.
- Ms. Lily Qi, Assistant Chief Administrative Officer, Montgomery County Office of the County Executive
- Ms. Sharon Ayd, Chief Scientific Officer and Senior VP Pharmaceuticals, Regulatory Compliance Associates Inc.
Technologists and entrepreneurs are reshaping cities like Baltimore with companies that bring new residents and products that change how we interact with the landscape. With a new mayor set to take office in Baltimore following the November 8 general election, it’s worth considering what the tech community wants to see at City Hall.
Ike Leggett says he will not seek a fourth term as Montgomery County executive.
Leggett, a former Howard University law professor who became the county’s first African American councilman and county executive, first announced publicly Sunday he would not run again at a fundraiser for an anti-term-limits group.
The Rockville biotech says two versions of its ADHD drug could serve a potential $7 billion market.
Historically prizes have been surprisingly effective at kickstarting innovation, will Deloitte's XPRIZE do the same?
Curing cancer is the holy grail of the medical and scientific communities, but a simple prize could make a whole lot of difference.
Wed, Oct 26, 2016 at 5:30 PM - Columbus Center 701 East Pratt Street Baltimore, MD
1st Pitch Life Science is coming to Baltimore for the first time. Hear what happens AFTER a start-up company presents to an investor group! Usually after a pitch, the investors have a closed-door discussion to decide whether the opportunity merits further investigation and possible investment. 1st Pitch Life Science (http://www.1stpitchlifescience.com) offers presenters and audience members the chance to hear what happens in those closed-door discussions, and to learn what really matters to investors.
BioBuzz and Elite Sponsor the Institute for Bioscience and Biotechnology Research (IBBR) are excited to announce a special event that lands right in the middle of the Oktoberfest season. Flying Dog Brewery will be our guest as we bring together the worlds of biotech and beer to show how closely related they really are. We are proud to have BioBuzz Double Helix Sponsors CRB and BREP along with Azzur IT as Co-Sponsors for this event.
Before the general networking begins, Flying Dog CEO, Jim Caruso, and COO/Head Brew Master, Matt Brophy will be on the IBBR Auditorium stage from 5:00 p.m. - 6:00 p.m. to speak about the company and everything that goes into the process of brewing their beer.
Supported by a $9 million grant from the National Cancer Institute, a multidisciplinary team led by Johns Hopkins researchers has begun looking for new ways to attack one of the scariest traits of this disease: its frequent refusal to stay in one place.
The new funding, to be allocated over a five-year period, will enable scholars in physical sciences, engineering, applied mathematics, cancer biology, and other disciplines to pool their expertise to solve stubborn cancer-related mysteries.
We're pleased to announce the release of the Johns Hopkins Technology Ventures fiscal year 2016 annual report - for the first time in digital format! Last year, we took tremendous strides in realizing our mission to benefit people around the world through innovation and to invigorate the local Baltimore economy. We saw a record number of disclosures, significant growth in our corporate partnerships, the creation of more startups than ever before, and substantial progress on the buildout of new state-of-the-art facilities. While we're proud of our accomplishments, there's more to do. We are using the facts and figures in this report to identify the paths that led to success and to develop strategies that build upon our progress.
The National Science Foundation has awarded $3.45 million over the next five years to renew its Innovation Corps program D.C.-area node to support entrepreneurship. George Washington University works alongside three additional collaborating institutions to train entrepreneurial student and faculty researchers and help them bring their discoveries to market.
The innovation hubs, known as I-Corps nodes, provide research infrastructure and training that help researchers transition fundamental science and engineering discoveries to the marketplace, according to NSF. The nodes also support I-Corps sites nationwide and offer seven-week I-Corps curriculum to their teams.
On Jan. 20, 2015, about 30 minutes into his State of the Union Address, President Barack Obama said the words that would set in motion a health research initiative that could exceed the scope of any that has come before it.
Obama told listeners that he was green-lighting the launch of the Precision Medicine Initiative, a program two decades in the making that would begin where the groundbreaking Human Genome Project left off.
The Clark Charitable Foundation gifted Johns Hopkins University $15 million to provide financial aid and create a new academic program for undergraduate engineering students.
The gift honors the late A. James Clark, a former trustee of the university and of Johns Hopkins Medicine and former CEO of Clark Enterprises and Clark Construction Group LLC, one of the country’s largest privately held general building contractors. It is the largest endowed scholarship gift ever given to the university’s Whiting School of Engineering.
Today CosmosID announced participation in Vice President Biden's National Cancer Moonshot, which aims to accelerate progress in preventing, diagnosing, and treating cancer. CosmosID will provide access to its automated bioinformatics platform, MetaGenID, for five cancer microbiome research studies (valued at $150,000) to understand how the microbiome (i.e. oral, gut, and skin) contributes to development of specific cancers.
Facing federal and state pressure to raise retention and graduation rates, dozens of colleges and universities are developing analytics tools to help students make better decisions about everything from courses to social activities.
Purdue University has notified its 7,300 incoming freshman about a new web application that could help them better acclimate to life on campus. Administrators at the West Lafayette, Ind., school view the software as a critical tool for an institution whose graduation rate hovers at around 50 percent.
PricewaterhouseCoopers published its quarterly MoneyTree Report Friday showing that startups of all stripes garnered a total of $10.6 billion through 891 deals nationwide. However, the deal value and the number of deals fell 36 percent and 25 percent respectively from the same quarter last year.
Venture capitalists invested $19.6 million in Maryland companies in the third quarter, the lowest total in any quarter since 1997.
The total investment represents a 76 percent decrease from the second quarter and is down 86 percent from the third quarter last year, according to a MoneyTree Report from PricewaterhouseCoopers LLP and the National Venture Capital Association, based on data provided by Thomson Reuters.
An affiliate of Alexandria Real Estate Equities Inc. (NYSE: ARE), an urban office REIT based in Pasadena, Calif., has purchased Torrey Ridge Science Center in San Diego’s Torrey Pines submarket. Walton Street Capital and SteelWave sold the campus to Alexandria for $182.5 million.
Torrey Ridge Science Center is a Class A life science campus leased to companies such as Regulus Therapeutics, Pacira Pharmaceuticals, Nitto BioPharma, Interpreta and BP Technology Ventures. The three-building, 291,799-square-foot campus was 87 percent leased at the time of sale.
MD Start, a European medical technology accelerator, announced Thursday that it has raised $11.5 million to create and fund four new French companies that can fulfill unmet needs in the medical device market.
The round was led by French Tech Acceleration Fund managed by Bpifrance, a French public investment bank. Other returning investors were French venture capital firm Sofinnova Partners, Dublin-based Medtronic, and LivaNova, a London-based medical device company.
Wed, Nov 16, 2016 at 6:00 PM
Five Top Intellectual Property Legal Experts and a Room Filled with Life Science and Healthcare Entrepreneurs…what could possibly happen?
Strategies for Start-ups (and Non-Start-ups) to Maintain, Protect and Unlock their Intellectual Property
The workshop is intended for non-lawyers to understand IP issues and answer questions on just about every aspect of IP including; Copyrights, Trade Secrets, Trademarks, Patents, licensing, IP Due Diligence, IP Strategy, etc.
Redwood City, California-based medical device company Relievant Medsystems Inc has raised $36 million in funding. New Enterprise Associates led the round with participation from Canaan Partners, Emergent Medical Partners and Morgenthaler Ventures.
A partnership between the University System of Maryland and Prince George's County schools led to increased student interest in STEM fields, higher scores on the science portion of Maryland State Assessments and more students entering STEM fields in college, according to the project's final report.
The USM's Math Science Partnership Minority Student Pipeline aimed "to expand the minority student pipeline in science, technology, engineering, and mathematics (STEM) fields in higher education, by employing strategies engaging STEM faculty, teachers, undergraduates and high school students," the report read. The USM's Education Policy and Student Life Committee reviewed the report on Sept. 20.
I have just downloaded the app Uberstand to my phone — the "revolutionary" app that seamlessly converts academics into a standing reserve of mobile, on-demand, adjunct knowledge providers. The app is designed to meet the real-time needs of institutes of higher learning and their customers, who often find themselves operating with a knowledge deficit, or what the industry terms a "need-to-know."